Kingworld Medicines Group (HKSE:01110) Construction In Progress: HK$106 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01110 Kingworld Medicines Group Ltd HKSE:01110
43 GF Score
Price HK$0.48
GF Value HK$0.50
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Kingworld Medicines Group Construction In Progress?

Kingworld Medicines Group HKSE:01110 -2.06% 43 Construction In Progress is HK$106 Mil as of Dec. 2025. GuruFocus rates HKSE:01110 with a GF Score™ of 43/100 and a GF Value™ of HK$0.50 (Fairly Valued). The stock has 5 warning signs investors should review.

Kingworld Medicines Group's quarterly construction in progress declined from Dec. 2024 (HK$1 Mil) to Jun. 2025 (HK$0 Mil) but then increased from Jun. 2025 (HK$0 Mil) to Dec. 2025 (HK$106 Mil).

Kingworld Medicines Group's annual construction in progress declined from Dec. 2023 (HK$223 Mil) to Dec. 2024 (HK$1 Mil) but then increased from Dec. 2024 (HK$1 Mil) to Dec. 2025 (HK$106 Mil).

Kingworld Medicines Group Construction In Progress Historical Data

* Premium members only.

The historical data trend for Kingworld Medicines Group's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kingworld Medicines Group Construction In Progress Chart

Kingworld Medicines Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.27 129.91 223.25 0.64 106.26

Kingworld Medicines Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 223.25 0.00 0.64 0.00 106.26
HKSE:01110
43GF Score
Kingworld Medicines Group Ltd HKSE:01110
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kingworld Medicines Group Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of HK$106 Mil mean?
Kingworld Medicines Group (HKSE:01110) has a Construction In Progress of HK$106 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Kingworld Medicines Group and its competitors.
Is Kingworld Medicines Group's Construction In Progress too high?
Kingworld Medicines Group's current Construction In Progress is HK$106 Mil. Overall, Kingworld Medicines Group has a GF Score™ of 43/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kingworld Medicines Group's Construction In Progress compare to competitors?
Kingworld Medicines Group's Construction In Progress of HK$106 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Healthcare Providers & Services company?
A good Construction In Progress depends on the Healthcare Providers & Services industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Kingworld Medicines Group and its competitors. Kingworld Medicines Group's current Construction In Progress is HK$106 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kingworld Medicines Group stock overvalued right now?
Based on GuruFocus' analysis, Kingworld Medicines Group (HKSE:01110) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.50, compared to a current price of HK$0.48 — trading 5% below its estimated fair value. The current Construction In Progress is HK$106 Mil. Kingworld Medicines Group's overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Kingworld Medicines Group (HKSE:01110), the current Construction In Progress is HK$106 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kingworld Medicines Group (HKSE:01110) Overvalued in 2026?

Based on GuruFocus' analysis, Kingworld Medicines Group stock appears to be undervalued. The current stock price of HK$0.48 is trading 5% below its estimated GF Value™ of HK$0.50. GuruFocus considers Kingworld Medicines Group to be Fairly Valued.

Key valuation signals for HKSE:01110:

  • Construction In Progress: HK$106 Mil
  • GF Value™: HK$0.50 vs. price of HK$0.48 (5% below fair value)
  • GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the HKSE:01110 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kingworld Medicines Group Business Description

Address 198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016
Kingworld Medicines Group Ltd is engaged in the Distribution of pharmaceutical and healthcare products, such as branded imported pharmaceutical and healthcare products in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices carried out in the PRC. It derives the majority of its revenue from the Distribution sales of the pharmaceutical and healthcare products segment.
43GF Score

Get the complete analysis for HKSE:01110

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.48
Price
HK$0.50
GF Value